6 reports of this reaction
2.5% of all GUAIFENESIN AND DEXTROMETHORPHAN HBR reports
#7 most reported adverse reaction
PNEUMONIA is the #7 most commonly reported adverse reaction for GUAIFENESIN AND DEXTROMETHORPHAN HBR, manufactured by CVS Pharmacy. There are 6 FDA adverse event reports linking GUAIFENESIN AND DEXTROMETHORPHAN HBR to PNEUMONIA. This represents approximately 2.5% of all 244 adverse event reports for this drug.
Patients taking GUAIFENESIN AND DEXTROMETHORPHAN HBR who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for GUAIFENESIN AND DEXTROMETHORPHAN HBR, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for GUAIFENESIN AND DEXTROMETHORPHAN HBR:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 6 FDA reports for GUAIFENESIN AND DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.5% of all adverse event reports for GUAIFENESIN AND DEXTROMETHORPHAN HBR, making it a notable side effect.
If you experience pneumonia while taking GUAIFENESIN AND DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.